Structural basis of substrate specificity and protease inhibition in norwalk virus

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4281-4292

  Muhaxhiri, Zana ^a   Deng, Lisheng ^a   Shanker, Sreejesh ^a   Sankaran, Banumathi ^a   Estes, Mary K ^b   Palzkill, Timothy ^a   Song, Yongcheng ^a   Prasad, Venkataram ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR; SYC 08; SYC 10; SYC 59; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; COVALENT BOND; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; FLUORESCENCE RESONANCE ENERGY TRANSFER; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS REPLICATION;

CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; NORWALK VIRUS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

NOROVIRUS ISOLATES; NORWALK VIRUS;

EID: 84875795282     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02869-12     Document Type: Article

References (48)

1. Green KY. 2007. Caliciviridae: the noroviruses, p 949-979. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323.
3. Hardy ME, Estes MK. 1996. Completion of the Norwalk virus genome sequence. Virus Genes 12:287-290.
4. Jiang X, Wang M, Wang K, Estes MK. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61.
5. Belliot G, Sosnovtsev SV, Mitra T, Hammer C, Garfield M, Green KY. 2003. In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells. J. Virol. 77:10957-10974.
6. Blakeney SJ, Cahill A, Reilly PA. 2003. Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase. Virology 308: 216-224.
7. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, selfassembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
8. Glass PJ, White LJ, Ball JM, Leparc-Goffart I, Hardy ME, Estes MK. 2000. Norwalk virus open reading frame 3 encodes a minor structural protein. J. Virol. 74:6581-6591.
9. Ettayebi K, Hardy ME. 2003. Norwalk virus nonstructural protein p48 forms a complex with the SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G protein. J. Virol. 77:11790-11797.
10. Pfister T, Wimmer E. 2001. Polypeptide p41 of a Norwalk-like virus is a nucleic acid-independent nucleoside triphosphatase. J. Virol. 75:1611-1619.
11. Sharp TM, Guix S, Katayama K, Crawford SE, Estes MK. 2010. Inhibition of cellular protein secretion by Norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS One 5:e13130. doi:10.1371/journal.pone.0013130.
12. Daughenbaugh KF, Fraser CS, Hershey JW, Hardy ME. 2003. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. EMBO J. 22:2852-2859.
13. Someya Y, Takeda N, Miyamura T. 2005. Characterization of the norovirus 3C-like protease. Virus Res. 110
14. Zeitler CE, Estes MK, Venkataram Prasad BV. 2006. X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J. Virol. 80:5050-5058.
15. Ng KK, Pendas-Franco N, Rojo J, Boga JA, Machin A, Alonso JM, Parra F. 2004. Crystal structure of Norwalk virus polymerase reveals the carboxyl terminus in the active site cleft. J. Biol. Chem. 279:16638-16645.
16. Zamyatkin DF, Parra F, Alonso JM, Harki DA, Peterson BR, Grochulski P, Ng KK. 2008. Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase. J. Biol. Chem. 283:7705-7712.
17. Hardy ME, Crone TJ, Brower JE, Ettayebi K. 2002. Substrate specificity of the Norwalk virus 3C-like proteinase. Virus Res. 89:29-39.
18. Sosnovtsev SV, Garfield M, Green KY. 2002. Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome. J. Virol. 76:7060-7072.
19. Bazan JF, Fletterick RJ. 1988. Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc. Natl. Acad. Sci. U. S. A. 85:7872-7876.
20. Boniotti B, Wirblich C, Sibilia M, Meyers G, Thiel HJ, Rossi C. 1994. Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus. J. Virol. 68:6487-6495.
21. Liu B, Clarke IN, Lambden PR. 1996. Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis. J. Virol. 70:2605-2610.
22. Liu BL, Viljoen GJ, Clarke IN, Lambden PR. 1999. Identification of further proteolytic cleavage sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli. J. Gen. Virol. 80:291-296.
23. Seah EL, Marshall JA, Wright PJ. 1999. Open reading frame 1 of the Norwalk-like virus Camberwell: completion of sequence and expression in mammalian cells. J. Virol. 73:10531-10535.
24. Someya Y, Takeda N, Miyamura T. 2000. Complete nucleotide sequence of the Chiba virus genome and functional expression of the 3C-like protease in Escherichia coli. Virology 278:490-500.
25. Scheffler U, Rudolph W, Gebhardt J, Rohayem J. 2007. Differential cleavage of the norovirus polyprotein precursor by two active forms of the viral protease. J. Gen. Virol. 88:2013-2018.
26. Leen EN, Baeza G, Curry S. 2012. Structure of a murine norovirus NS6 protease-product complex revealed by adventitious crystallisation. PLoS One 7:e38723. doi:10.1371/journal.pone.0038723.
27. Nakamura K, Someya Y, Kumasaka T, Ueno G, Yamamoto M, Sato T, Takeda N, Miyamura T, Tanaka N. 2005. A norovirus protease structure provides insights into active and substrate binding site integrity. J. Virol. 79:13685-13693.
28. Hussey RJ, Coates L, Gill RS, Erskine PT, Coker SF, Mitchell E, Cooper JB, Wood S, Broadbridge R, Clarke IN, Lambden PR, Shoolingin-Jordan PM. 2011. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor. Biochemistry 50:240-249.
29. Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. U. S. A. 96:11000-11007.
30. Copeland RA. 2002. Enzymes, 2nd ed. Wiley-VCH, New York, NY.
31. Otwinowski Z. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
32. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40: 658-674.
33. Collaborative Computational Project. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763.
34. Morris RJ, Perrakis A, Lamzin VS. 2003. ARP/wARP and automatic interpretation of protein electron density maps. Methods Enzymol. 374: 229-244.
35. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132.
36. Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240-255.
37. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213-221.
38. Painter J, Merritt EA. 2006. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62:439-450.
39. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8:477-486.
40. Schrodinger, LLC. 2011. The PyMOL molecular graphics system, 1.5.0.4. Schrodinger, LLC, Portland, OR.
41. Someya Y, Takeda N. 2009. Insights into the enzyme-substrate interaction in the norovirus 3C-like protease. J. Biochem. 146:509-521.
42. Webber SE, Okano K, Little TL, Reich SH, Xin Y, Fuhrman SA, Matthews DA, Love RA, Hendrickson TF, Patick AK, Meador JW, 3rd, Ferre RA, Brown EL, Ford CE, Binford SL, Worland ST. 1998. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. J. Med. Chem. 41:2786-2805.
43. Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, Reich SH, Marakovits JT, Prins TJ, Zhou R, Tikhe J, Littlefield ES, Bleckman TM, Wallace MB, Little TL, Ford CE, Meador JW, 3rd, Ferre RA, Brown EL, Binford SL, DeLisle DM, Worland ST. 1998. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structureactivity studies. J. Med. Chem. 41:2819-2834.
44. Phan J, Zdanov A, Evdokimov AG, Tropea JE, Peters HK, 3rd, Kapust RB, Li M, Wlodawer A, Waugh DS. 2002. Structural basis for the substrate specificity of tobacco etch virus protease. J. Biol. Chem. 277:50564-50572.
45. Goetz DH, Choe Y, Hansell E, Chen YT, McDowell M, Jonsson CB, Roush WR, McKerrow J, Craik CS. 2007. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry 46:8744-8752.
46. Perona JJ, Craik CS. 1995. Structural basis of substrate specificity in the serine proteases. Protein Sci. 4:337-360.
47. Someya Y, Takeda N. 2011. Functional consequences of mutational analysis of norovirus protease. FEBS Lett. 585:369-374.
48. Kim Y, Lovell S, Tiew KC, Mandadapu SR, Alliston KR, Battaile KP, Groutas WC, Chang KO. 2012. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J. Virol. 86:11754-11762.